Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Journal of Neuro-Oncology
|
May 29, 2023
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
Lily A McLaughlin, Onur Yildirim, Marc K Rosenblum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
Journal of Neuro-Oncology
|
August 23, 2022
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
Brandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of Neuro-Oncology
|
July 27, 2022
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
Brandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2025
Immunotheranostics in Solid Tumors: Longitudinal Tracking of Human IL13Rα2 CAR-T Cells In Vivo
Hamid Reza Mirzaei, Samantha Lovibond, Leah Gajecki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2025
Symptomatic Prostate-Specific Membrane Antigen PET-Positive Radionecrosis After Multimodality Brain Metastasis-Directed Treatment Including [<sup>177</sup>Lu]Lu-PSMA-617
Brandon S Imber, Kenny Kwok Hei Yu, Wassim Abida, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Leah Gajecki, Irina V Lebedeva, Yu-Rou Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 14, 2013
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma
Meenakshi Hegde, Amanda Corder, Kevin K H Chow, et al.
Bioconjugate Chemistry
|
April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications
Megan M Dacek, Darren R Veach, Sarah M Cheal, et al.
The Journal of Clinical Investigation
|
July 1, 2021
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Journal of Neuro-Oncology
|
May 29, 2023
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
Lily A McLaughlin, Onur Yildirim, Marc K Rosenblum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
Journal of Neuro-Oncology
|
August 23, 2022
Correction to: Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
Brandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of Neuro-Oncology
|
July 27, 2022
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases
Brandon S Imber, Robert J Young, Kathryn Beal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2025
Immunotheranostics in Solid Tumors: Longitudinal Tracking of Human IL13Rα2 CAR-T Cells In Vivo
Hamid Reza Mirzaei, Samantha Lovibond, Leah Gajecki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2025
Symptomatic Prostate-Specific Membrane Antigen PET-Positive Radionecrosis After Multimodality Brain Metastasis-Directed Treatment Including [<sup>177</sup>Lu]Lu-PSMA-617
Brandon S Imber, Kenny Kwok Hei Yu, Wassim Abida, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 20, 2025
IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
Leah Gajecki, Irina V Lebedeva, Yu-Rou Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 14, 2013
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma
Meenakshi Hegde, Amanda Corder, Kevin K H Chow, et al.
Bioconjugate Chemistry
|
April 5, 2021
Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications
Megan M Dacek, Darren R Veach, Sarah M Cheal, et al.
The Journal of Clinical Investigation
|
July 1, 2021
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, et al.
Page
of 6